Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-02

Clinical Trial Update: Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ceftriaxone plus azithromycin versus ceftriaxone for gonorrhea has completed, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Neisseria Gonorrhoeae | Phase 4 | Status: COMPLETED | Results posted: 2024-08-02